ARTV
Artiva Biotherapeutics, Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P. bought $7.7M of Artiva Biotherapeutics, Inc.
Director
Bought$7,650,148
$7.44Price
1,027,722Shares
+7%Stake
What ARTV did for a copier
- $1,000 copied at Fri, Jun 12 open, $8.61
- $1,223
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Jul 28 close.
RA CAPITAL MANAGEMENT, L.P.'s record
63 other buys with 3 months of prices since 2016: on average −0.2% against the S&P 500, and 22 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jun 9. Filed Thu, Jun 11, 7:36 PM ET, after the close. Returns use the Jun 12 open and the Jul 28 close. Not investment advice.